Pharvaris N.V.
PHVS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001830487
In the last 90 days, Pharvaris N.V. insiders filed 0 open-market purchases and 20 sales; 125 institutions reported holding it in 13F filings for Q2 2026, worth $2.23B in total; Viking Global Investors is the only superinvestor holding it.
13F holders, Q4 2024
Institutional positions in Pharvaris N.V. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 54
- +3 vs. Q3 2024
- Shares held
- 44.6M
- −401.3K (−0.9%) vs. Q3 2024
- Total value
- $855.8M
- +$21.6M (+2.6%) vs. Q3 2024
- New holders
- 9
- 19 more added
- Sold out
- 6
- 12 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PHVS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 125 | $2.23B |
| Q1 2026 | 110 | $1.67B |
| Q4 2025 | 106 | $1.64B |
| Q3 2025 | 83 | $1.44B |
| Q2 2025 | 60 | $792.7M |
| Q1 2025 | 52 | $705.5M |
| Q4 2024 | 54 | $855.8M |
| Q3 2024 | 51 | $834.2M |
| Q2 2024 | 36 | $808.6M |
| Q1 2024 | 35 | $980.5M |
| Q4 2023 | 36 | $1.14B |
| Q3 2023 | 21 | $606.6M |
| Q2 2023 | 21 | $441.6M |
| Q1 2023 | 21 | $173.9M |
| Q4 2022 | 25 | $239.6M |
| Q3 2022 | 21 | $173.6M |
| Q2 2022 | 20 | $494.0M |
| Q1 2022 | 22 | $397.1M |
| Q4 2021 | 22 | $321.1M |
| Q3 2021 | 25 | $380.3M |
| Q2 2021 | 28 | $406.3M |
| Q1 2021 | 33 | $616.5M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Pharvaris N.V.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| SBI Securities Co., Ltd. | 11 | $211 | 0.00% | +11 | New |
| BNP Paribas Arbitrage, SA | 100 | $1.92K | 0.00% | +100 | New |
| Amundi | 143 | $2.65K | 0.00% | +59+70.2% | Added |
| Citigroup Inc | 543 | $10.4K | 0.00% | +543 | New |
| Wells Fargo & Company | 800 | $15.3K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,045 | $20.0K | 0.00% | −546−34.3% | Reduced |
| Police & Firemen's Retirement System of New Jersey | 2,369 | $45.4K | 0.00% | +2,369 | New |
| Barclays PLC | 2,864 | $54.9K | 0.00% | −2,836−49.8% | Reduced |
| JPMorgan Chase & Co | 3,100 | $59.4K | 0.00% | +2,847+1,125.3% | Added |
| Cubist Systematic Strategies, LLC | 3,336 | $63.9K | 0.00% | +3,336 | New |
| Public Employees Retirement System of Ohio | 3,500 | $67.1K | 0.00% | +400+12.9% | Added |
| Virtus ETF Advisers LLC | 3,738 | $71.7K | 0.03% | −1,351−26.5% | Reduced |
| KLP Kapitalforvaltning AS | 5,800 | $111.2K | 0.00% | +5,800 | New |
| Point72 Asset Management, L.P. | 7,921 | $151.8K | 0.00% | +7,921 | New |
| Legal & General Group Plc | 9,855 | $188.9K | 0.00% | +994+11.2% | Added |
| Palumbo Wealth Management LLC | 10,221 | $195.9K | 0.07% | +10,221 | New |
| Vanguard Group Inc | 12,740 | $244.2K | 0.00% | 00.0% | Unchanged |
| California State Teachers Retirement System | 13,426 | $257.4K | 0.00% | +476+3.7% | Added |
| Millennium Management LLC | 17,731 | $339.9K | 0.00% | −6,576−27.1% | Reduced |
| Deutsche Bank AG | 18,168 | $348.3K | 0.00% | +2,087+13.0% | Added |
| HighVista Strategies LLC | 22,768 | $436.5K | 0.16% | 00.0% | Unchanged |
| Swiss National Bank | 26,257 | $503.3K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 26,997 | $517.5K | 0.00% | +2,746+11.3% | Added |
| Bank of America Corp | 30,808 | $590.6K | 0.00% | +30,793+205,286.7% | Added |
| HealthInvest Partners AB | 34,328 | $652.9K | 0.31% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 38,333 | $734.8K | 0.00% | +1,356+3.7% | Added |
| Manufacturers Life Insurance Company, The | 40,978 | $785.5K | 0.00% | −3,900−8.7% | Reduced |
| Alps Advisors Inc | 43,671 | $837.2K | 0.01% | +1,363+3.2% | Added |
| Goldman Sachs Group Inc | 44,247 | $848.2K | 0.00% | −19,583−30.7% | Reduced |
| Woodline Partners LP | 44,514 | $853.3K | 0.01% | +44,514 | New |
| TD Asset Management Inc | 55,216 | $1.06M | 0.00% | +19,000+52.5% | Added |
| UBS Asset Management Americas Inc | 63,734 | $1.22M | 0.00% | +14,838+30.3% | Added |
| Northern Trust Corp | 91,932 | $1.76M | 0.00% | +76,188+483.9% | Added |
| State Street Corp | 92,006 | $1.76M | 0.00% | +38,026+70.4% | Added |
| BlackRock, Inc. | 194,195 | $3.72M | 0.00% | −1,153−0.6% | Reduced |
| Patient Square Capital LP | 207,603 | $3.98M | 1.49% | −34,738−14.3% | Reduced |
| Sphera Funds Management Ltd. | 388,183 | $7.44M | 1.37% | −51,109−11.6% | Reduced |
| Price T Rowe Associates Inc | 443,896 | $8.51M | 0.00% | +118,408+36.4% | Added |
| Sofinnova Investments, Inc. | 560,723 | $10.7M | 0.79% | −39,579−6.6% | Reduced |
| Rock Springs Capital Management LP | 775,131 | $14.9M | 0.57% | +18,200+2.4% | Added |
| Octagon Capital Advisors LP | 778,000 | $14.9M | 2.54% | +157,530+25.4% | Added |
| 5AM Venture Management, LLC | 797,600 | $15.3M | 3.65% | 00.0% | Unchanged |
| Soleus Capital Management, L.P. | 814,652 | $15.6M | 1.18% | +216,483+36.2% | Added |
| Cormorant Asset Management, LP | 1,466,460 | $28.1M | 1.54% | 00.0% | Unchanged |
| Novo Holdings A/S | 1,725,000 | $33.1M | 2.00% | 00.0% | Unchanged |
| Commodore Capital LP | 1,911,433 | $36.6M | 2.69% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 2,017,464 | $38.7M | 0.74% | −14,236−0.7% | Reduced |
| VR Adviser, LLC | 3,220,130 | $61.7M | 4.24% | −175,476−5.2% | Reduced |
| Bain Capital Life Sciences Investors, LLC | 3,303,381 | $63.3M | 7.45% | 00.0% | Unchanged |
| Viking Global Investors LPSuperinvestorViking Global Investors | 3,653,310 | $70.0M | 0.23% | 00.0% | Unchanged |
| venBio Partners LLC | 4,289,304 | $82.2M | 48.17% | 00.0% | Unchanged |
| Foresite Capital Management IV, LLC | 4,397,881 | $84.3M | 77.49% | 00.0% | Unchanged |
| FMR LLC | 5,395,370 | $103.4M | 0.01% | +189,714+3.6% | Added |
| General Atlantic LLC | 7,531,252 | $144.4M | 5.14% | 00.0% | Unchanged |
| EcoR1 Capital, LLC | 0 | $0 | 0.00% | −900,000−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −59,014−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −28,418−100.0% | Sold out |
| Crestline Management, LP | 0 | $0 | 0.00% | −15,819−100.0% | Sold out |
| Ghisallo Capital Management LLC | 0 | $0 | 0.00% | −11,249−100.0% | Sold out |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |